Sowell Financial Services LLC Karyopharm Therapeutics Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$8.11 - $11.11 $10,178 - $13,943	-1,255 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$9.85 - $17.69 $1,004 - $1,804	102 Added 8.85%	1,255 $10,000
Q4 2020 Jan 13, 2021	BUY	$14.15 - $17.19 $14,560 - $17,688	1,029 Added 829.84%	1,153 $18,000
Q3 2020 Nov 12, 2020	SELL	$14.14 - $19.71 $3,054 - $4,257	-216 Reduced 63.53%	124 $2,000
Q2 2020 Aug 13, 2020	SELL	$16.6 - $25.25 $22,011 - $33,481	-1,326 Reduced 79.59%	340 $6,000
Q1 2020 May 12, 2020	SELL	$14.38 - $27.72 $29,018 - $55,938	-2,018 Reduced 54.78%	1,666 $32,000
Q4 2019 Feb 07, 2020	BUY	$9.23 - $19.67 $34,003 - $72,464	3,684 New	3,684 $70,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67.8M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.